Hyaluronic Acid Nanoparticles as Nanomedicine for Treatment of Inflammatory Diseases

被引：47
|
作者：
Rao, N. Vijayakameswara [1 ,2 ]
Rho, Jun Gi [3 ]
Um, Wooram [1 ]
EK, Pramod Kumar [1 ]
Nguyen, Van Quy [1 ]
Oh, Byeong Hoon [1 ]
Kim, Wook [3 ]
Park, Jae Hyung [1 ,4 ]
机构：
[1] Sungkyunkwan Univ, Sch Chem Engn, Suwon 16419, South Korea
[2] Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Taipei 10617, Taiwan
[3] Ajou Univ, Dept Mol Sci & Technol, Suwon 16499, South Korea
[4] Sungkyunkwan Univ, Dept Biomed Inst Convergence SKKU BICS, Suwon 16419, South Korea
来源：
PHARMACEUTICS | 2020年 / 12卷 / 10期
基金：
新加坡国家研究基金会;
关键词：
hyaluronic acid; drug conjugates; polymeric nanoparticles; tumor-targeting; targeted-therapy; inflammatory diseases; type; 2; diabetes; atherosclerosis; GENOME-WIDE ASSOCIATION; MOLECULAR-WEIGHT; INSULIN-RESISTANCE; ORAL DELIVERY; RECEPTOR CD44; TISSUE-INJURY; IN-VIVO; TUMOR; MACROPHAGES; NANOCARRIERS;
D O I：
10.3390/pharmaceutics12100931
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Owing to their unique biological functions, hyaluronic acid (HA) and its derivatives have been explored extensively for biomedical applications such as tissue engineering, drug delivery, and molecular imaging. In particular, self-assembled HA nanoparticles (HA-NPs) have been used widely as target-specific and long-acting nanocarriers for the delivery of a wide range of therapeutic or diagnostic agents. Recently, it has been demonstrated that empty HA-NPs without bearing any therapeutic agent can be used therapeutically for the treatment of inflammatory diseases via modulating inflammatory responses. In this review, we aim to provide an overview of the significant achievements in this field and highlight the potential of HA-NPs for the treatment of inflammatory diseases.
引用
收藏
页码：1 / 18
页数：18
相关论文
共 50 条
  • [31] Hyaluronic acid-doxorubicin nanoparticles for targeted treatment of colorectal cancer
    Pan, Daniel C.
    Krishnan, Vinu
    Salinas, Alyssa K.
    Kim, Jayoung
    Sun, Tao
    Ravid, Sagi
    Peng, Kevin
    Wu, Debra
    Nurunnabi, Md
    Nelson, Jeffery A.
    Niziolek, Zachary
    Guo, Junling
    Mitragotri, Samir
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2021, 6 (01)
  • [32] Hyaluronic acid concentration in liver diseases
    Monika Gudowska
    Ewa Gruszewska
    Anatol Panasiuk
    Bogdan Cylwik
    Robert Flisiak
    Magdalena Świderska
    Maciej Szmitkowski
    Lech Chrostek
    Clinical and Experimental Medicine, 2016, 16 : 523 - 528
  • [33] Hyaluronic acid concentration in liver diseases
    Gudowska, Monika
    Gruszewska, Ewa
    Panasiuk, Anatol
    Cylwik, Bogdan
    Flisiak, Robert
    Aewiderska, Magdalena
    Szmitkowski, Maciej
    Chrostek, Lech
    CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 16 (04) : 523 - 528
  • [34] Application of hyaluronic acid in tissue engineering, regenerative medicine, and nanomedicine: A review
    Saravanakumar, Kandasamy
    Park, SeonJu
    Santosh, Sugavaneswaran Siva
    Ganeshalingam, Archchana
    Thiripuranathar, Gobika
    Sathiyaseelan, Anbazhagan
    Vijayasarathy, Sampathkumar
    Swaminathan, Akila
    Priya, Veeraraghavan Vishnu
    Wang, Myeong-Hyeon
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 222 : 2744 - 2760
  • [35] Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy
    Yonghyun Lee
    Jongyoon Shinn
    Cheng Xu
    Hannah E. Dobson
    Nouri Neamati
    James J. Moon
    Nature Communications, 14
  • [36] Efficacy of hyaluronic acid in the treatment of nasal inflammatory diseases: a systematic review and meta-analysis (vol 15, 1350063, 2024)
    Liu, Huixia
    Chen, Yue
    Wang, Huan
    Luo, Xinyi
    Xie, Dengpiao
    Ji, Qing
    Tian, Li
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [37] Chitosan-hyaluronic acid nanoparticles for gene silencing: The role of hyaluronic acid on the nanoparticles' formation and activity
    Al-Qadi, Sonia
    Alatorre-Meda, Manuel
    Zaghloul, Eman M.
    Taboada, Pablo
    Remunan-Lopez, Carmen
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2013, 103 : 615 - 623
  • [38] Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy
    Lee, Yonghyun
    Shinn, Jongyoon
    Xu, Cheng
    Dobson, Hannah E.
    Neamati, Nouri
    Moon, James J.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [39] PROLONGED TREATMENT WITH TOLFENAMIC ACID IN INFLAMMATORY RHEUMATIC DISEASES
    KAJANDER, A
    MARTIO, J
    MUTRU, O
    GOTHONI, G
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1976, 5 (03) : 158 - 160
  • [40] Nanomedicine for the treatment of retinal and optic nerve diseases
    Zarbin, Marco Attilio
    Montemagno, Carlo
    Leary, James Francis
    Ritch, Robert
    CURRENT OPINION IN PHARMACOLOGY, 2013, 13 (01) : 134 - 148
12345